New hope for Hard-to-Control blood pressure: finerenone shows promise
NCT ID NCT06381323
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a drug called finerenone in 55 adults with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, leading to high blood pressure. The goal was to see if finerenone can safely lower blood pressure over 12 weeks. Participants started with a low dose, which could be increased if needed. The main focus was on how much daytime systolic blood pressure dropped.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Finerenone (a mineralocorticoid receptor antagonist)
- What this could lead to
- If successful, finerenone could offer a new treatment option to control blood pressure in patients with primary aldosteronism.
- What could go wrong
- This is a small, completed phase 4 trial with only 55 participants. Results may not apply to all patients, and finerenone may cause side effects like high potassium or kidney issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FINERENONE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Endocrinology, Drum Tower Hospital affiliated to Nanjing University Medical School
Nanjing, Jiangsu, 210008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable tech puts hormone health to the test
- New scan could replace risky vein test for Hormone-Driven high blood pressure
- New screening strategy could speed diagnosis of inherited aldosteronism
- Alcohol injection into adrenal tumors may offer surgery-free blood pressure control
- Sharper blood test could uncover hidden cause of high blood pressure
- New drug may offer safer option for Hormone-Driven high blood pressure